Smart Immune Email Format

Biotechnology ResearchÎle-de-France, France11-50 Employees

Smart Immune is a clinical-stage biotechnology company based in Paris, within the Île-de-France region, focused on developing ProTcell, a thymus-empowered T cell progenitor platform. The aim is to rapidly re-arm the immune system to treat cancer and infectious disease, enabling next-generation allogeneic T cell therapies. The company collaborates with leading institutions in the United States and Europe to advance its programs.

Its lead program, SMART101, is in Phase I/II trials for cancers such as AML and ALL, and for SCID in both the EU and the US. Smart Immune is pursuing therapies based on gene-modified T cell progenitors to support off-the-shelf T cell treatment options. In December 2023, the company appointed Dr. Rahim Fandi as Chief Medical Officer, reflecting ongoing clinical development activity.

Sign up for free to view info

Company overview Employee directory